top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

1 min read

Memo Therapeutics AG Appoints Erik van den Berg as CEO

Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier therapeutic antibodies, discloses the appointment of Erik van den Berg as Chief Executive Officer (CEO).

Read full article here.

Recent Posts

Terray Therapeutics Secures $120M in Series B Funding to Revolutionize Small Molecule Drug Development with Advanced AI

Los Angeles, CA, October 17, 2024 (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to...

ViaNautis Bio Appoints Dr. Adi Hoess as CEO to Propel Growth in Genetic Therapies

Cambridge, UK, October 18, 2024 ( GlobeNewswire ) -- ViaNautis Bio has appointed Dr. Adi Hoess as its new Chief Executive Officer,...

AvenCell Therapeutics Secures $112M in Series B Funding to Advance Innovative Switchable CAR-T Cell Therapies

Watertown, MA, October 22, 2024 (PRNewswire) -- AvenCell Therapeutics has secured $112 million in Series B funding to enhance its...

Comments

Life Science Headlines

Terray Therapeutics Secures $120M in Series B Funding to Revolutionize Small Molecule Drug Development with Advanced AI

ViaNautis Bio Appoints Dr. Adi Hoess as CEO to Propel Growth in Genetic Therapies

AvenCell Therapeutics Secures $112M in Series B Funding to Advance Innovative Switchable CAR-T Cell Therapies

Mike Alvarez Appointed CEO of Glooko to Drive Growth Following $100 Million Series F Financing

Seaport Therapeutics Secures $225M in Oversubscribed Series B Financing to Propel Neuropsychiatric Drug Development

ShiraTronics Series B Raises $66M

Keith Dionne, Ph.D. Appointed CEO of Luxa Biotechnology

CeriBell upsizes IPO, targets $578M valuation

Halda Therapeutics appoints Christian Schade as President and CEO to advance novel cancer therapies

Kailera Therapeutics raises $400M to advance next-generation obesity therapies

bottom of page